All stock lists
Armata Pharmaceuticals, Inc. (ARMP)
NYSE: ARMP · Real-Time Price · USD
Healthcare · Biotechnology
$2.99-$0.88 (-22.74%)
Insider Score
––Not scored
ARMP Insider Score
No insider has filed an open-market purchase or sale here in the last 90 days, so there is nothing to score yet.
ARMP Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Sep 30, 2026 | Jun 30, 2026 | Mar 31, 2026 | Dec 31, 2025 | Sep 30, 2025 | Jun 30, 2025 |
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Revenue Growth (YoY) | — | — | — | — | — | — |
| Cost of Revenue | — | — | — | — | — | — |
| Gross Profit | — | — | — | — | — | — |
| SG&A Expense | $3.72 M | $5.24 M | $3.46 M | $3.43 M | $3.11 M | — |
| R&D Expense | $6.83 M | $7.59 M | $6.11 M | $6.07 M | $5.82 M | — |
| Operating Expenses | $7.38 M | $10.31 M | $8.79 M | $8.41 M | $7.78 M | — |
| Operating Income | -$7.38 M | -$10.31 M | -$8.79 M | -$8.41 M | -$7.78 M | — |
| Pretax Income | $54.86 M | $74.14 M | -$115.35 M | -$124.30 M | -$26.68 M | — |
| Tax Provision | — | — | — | — | — | — |
| Net Income | $54.86 M | $74.14 M | -$115.35 M | -$124.30 M | -$26.68 M | — |
| EPS (Basic) | $1.15 | $2.02 | -$3.16 | — | -$0.74 | -$0.45 |
| EPS (Diluted) | -$0.24 | -$0.27 | -$3.16 | — | -$0.74 | -$0.45 |
| Shares Outstanding | 37.18 M | 36.75 M | 36.53 M | — | 36.23 M | 36.19 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
